Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

Abstract OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives. The European Headache Federation identified an expert group that was asked t...

Full description

Bibliographic Details
Main Authors: Lars Bendtsen, Simona Sacco, Messoud Ashina, Dimos Mitsikostas, Fayyaz Ahmed, Patricia Pozo-Rosich, Paolo Martelletti
Format: Article
Language:English
Published: BMC 2018-09-01
Series:The Journal of Headache and Pain
Subjects:
Chronic migraine
OnabotulinumtoxinA
Management
Guideline
Online Access:http://link.springer.com/article/10.1186/s10194-018-0921-8

Internet

http://link.springer.com/article/10.1186/s10194-018-0921-8

Similar Items